Evaluation of the quality of clinical research

In 2022–2023, the quality of clinical research will be evaluated in the seven ALF regions in Sweden. This evaluation is essential for maintaining and developing our excellent clinical research. Furthermore, and a significant part of the ALF funding is dependent on the results of this evaluation.

As part of the evaluation, some clinically active researchers and PhD students will be selected by the Swedish Research Council to, in the spring of 2022, respond to a questionnaire about the research environment at the Uppsala University Hospital and Uppsala University. The image that these surveys will give the evaluators will form the basis for the evaluation results.

Please note that the evaluation concerns all clinical research, not only those funded through ALF funds.

To inform about the evaluation, Uppsala University, the University Hospital and Region Uppsala will hold three information meetings on 29 November, 7 December and 9 December. We are especially addressing clinically active researchers and PhD students.

The purpose of the meetings is to provide an understanding of the evaluation and we discuss the significance of the evaluation results.

Choose the opportunity that suits you best:

Monday 29 November at 16: 15–17: 00
Uppsala University Hospital, entrance 10, Gunnesalen

Tuesday 7 December at 16: 15–17: 00
Uppsala University Hospital, entrance 10, Gunnesalen

Thursday 9 December at 16: 15-17: 00
Digitally via Zoom: uu-se.zoom.us/j/62803166853

Read more

Clinical research evaluated – “A large part of the ALF funding depends on our results”

Eva Tiensuu Janson and Peter Stålberg
Eva Tiensuu Janson, Dep. Vice-Rector, and Peter Stålberg, act. R&D Director
Last modified: 2021-11-17